Global Collaboration to Advance AI-Driven Discovery for Alzheimer's Prevention Announced

The Davos Alzheimer’s Collaborative (DAC) and the FINGERS Brain Health Institute (FBHI) today announced the expansion of their global collaboration, marking a pivotal step forward in the pursuit of precision prevention for Alzheimer’s disease. This deepened partnership affirms a shared commitment to accelerate the prevention of Alzheimer’s and related dementias by leveraging next generation artificial intelligence, globally representative data, and coordinated scientific leadership.

‍

This expansion reaffirms the partners’ shared commitment to promote prevention focused research and strengthen health system preparedness, identify opportunities for global cooperation and programmatic synergy and elevate prevention, and risk reduction priorities among policymakers, civil society leaders, and the private sector.‍

‍

About the Partners

‍The Davos Alzheimer’s Collaborative (DAC) is a global, multi stakeholder partnership dedicated to transforming the way the world prepares for and prevents Alzheimer’s disease. Founded at the World Economic Forum, DAC brings together leaders from research, industry, healthcare, and civil society to accelerate innovation, expand access to emerging tools for early detection, and ensure that advances in brain health benefit all populations equitably.

‍

‍

FINGERPRINT is an agentic artificial intelligence initiative advancing precision prevention and therapeutic discovery for Alzheimer’s disease. The multidisciplinary team includes leading scientists and clinicians, Prof. Miia Kivipelto, Prof. Giovanni Traverso, Prof. Li-Huei Tsai, Prof. Anna Matton, Prof. Alina Solomon, Prof. Francesca Mangialasche, Dr. Ludivine Morvan, Dr. Makrina Daniilidou, Dr. Daniel Mukasa, Dr. Isaac Tucker, and Dr. Deepak Subramanian, and is led by Dr. Adrián Noriega and Arvid Gollwitzer.